SCHEMBL2457599

SCHEMBL2457599

c1cc2cc(-c3ccsn3)ccc2[nH]1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.51
PSMB8 P28062 1/20 0.50
GUSB P08236 4/20 0.47
FYN P06241 1/20 0.47
NISCH Q9Y2I1 1/20 0.46
CYP17A1 P05093 1/20 0.45
CYP11B1 P15538 1/20 0.45
CYP11B2 P19099 1/20 0.45
BRD4 O60885 1/20 0.44
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
AHR P35869 3/20 0.43
NR4A2 P43354 2/20 0.43
CYP2A6 P11509 1/20 0.43
F7 P08709 1/20 0.43
LTA4H P09960 1/20 0.43
F3 P13726 1/20 0.43
USP2 O75604 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2460991 0.86 BRD4 (0.44) PSMB8BRD4AHRCYP2A6DYRK1B
SCHEMBL2458508 0.77 GSK3B (0.58) GAAMAPTDYRK3CDK9CDK5
SCHEMBL5850255 0.77 NPC1 (0.79) NPC1PSMB8GUSBFYNNISCH
SCHEMBL2461327 0.75 NPC1 (0.50) NPC1PSMB8GUSBFYNNISCH
SCHEMBL2461441 0.74 NPC1 (0.58) NPC1PSMB8GUSBNISCHCYP17A1
SCHEMBL2461339 0.73 NPC1 (0.49) NPC1PSMB8GUSBFYNNISCH
SCHEMBL3618672 0.73 CYP1A2 (0.56) NPC1CYP17A1CYP11B1CYP11B2CA12
SCHEMBL2457815 0.71 NPC1 (0.54) NPC1PSMB8GUSBFYNNISCH
SCHEMBL2457387 0.70 NPC1 (0.58) NPC1PSMB8GUSBFYNNISCH
SCHEMBL9093554 0.70 ROCK2 (0.64) NPC1FYNBRD4GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110237633-A1 SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2011-09-29 US disclosed
WO-2010068287-A2 SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY ANGION BIOMEDICA CORP. (US) 2010-06-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110237633-A1 SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY HGF, HDGF, MET NPC1 1244/4885PSMB8 3633/4885GUSB 1653/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.